Position in ABCL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$176,625
+$96,355 QoQ
Shares Held
22,500
-2.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#93
of 150 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Stratos Wealth Advisors, LLC holds $7,912,284 across 9 Biotechnology names. ABCL ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,630 | $5,381,150 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
16,585 | $948,993 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
7,022 | $385,788 | |
| 4 | EXEL |
Exelixis, Inc.
|
5,817 | $316,502 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
5,365 | $292,607 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421 | $209,123 | |
| 7 | ABCL |
AbCellera Biologics Inc.
This page
|
22,500 | $176,625 | |
| 8 | CADL |
Candel Therapeutics, Inc.
|
16,000 | $164,800 |
All Filings in ABCL
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $176,625 | 22,500 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $80,270 | 23,000 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $78,660 | 23,000 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $95,570 | 19,000 | Shares | Sole | 2025-11-06 | |
| 2025-03-31 | $26,760 | 12,000 | Shares | Sole | 2025-04-30 | |
| 2024-09-30 | $118,300 | 45,500 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $134,680 | 45,500 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $206,115 | 45,500 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $248,385 | 43,500 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $223,100 | 48,500 | Shares | Sole | 2023-10-24 | |
| No filing history on record for this holder in this stock. | ||||||